Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance.
- NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_assertion description "[Peptide hormones of the glucagon-like peptide (GLP) family play an increasing clinical role, as reported for GLP-1 in diabetes therapy and insulinoma diagnostics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance.
- NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_assertion evidence source_evidence_literature NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance.
- NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_assertion SIO_000772 22951144 NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance.
- NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_assertion wasDerivedFrom befree-20140225 NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance.
- NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_assertion wasGeneratedBy ECO_0000203 NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP186923.RA5Qadq1FL0TflVX8w_H_5DBe41y8N5y7TlqsjVjxaLmM130_provenance.